Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency
Samuel Hosford, Heather Austin-Robillard
Contemporary Family Therapy December 11, 2025 DOI: 10.1007/s10591-025-09766-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Narrative review Peer reviewed |
|---|---|
| Interventions | Psilocybin-assisted therapy MDMA |
| Topics | Addiction MDMA Psilocybin |
| Keywords | Spouse Substance abuse Substance use Dilemma Psychotherapist Clinical psychology Distress Addictive behavior |
| Key findings | Combining psilocybin-assisted therapy for substance use disorders and MDMA for codependency in couples therapy may reduce addictive behaviors in one partner and codependent behaviors in the other. |
Abstract
Abstract Substance use disorders (SUDs) are increasingly common in the United States, and while this may be a dilemma for those using, it also inflicts problems for those around the user. In couples where drug abuse is present, negative codependent characteristics can arise independently in the non-user, having a damaging effect on the couple dynamic. This is a narrative review to identify how psilocybin-assisted therapy (PAT) has been used to treat SUDs and 3,4-methylenedioxymethamphetamine (MDMA) for disorders like PTSD, examining how MDMA may also be able to treat codependency in a spouse uniquely afflicted by their counterpart’s addiction. When utilizing the combination of these two substances with couples therapy, a reduction of addictive characteristics in one client with a SUD may occur while also shifting codependent behaviors in the romantic partner. Clinical implications as well as limitations on current research are discussed along with further suggestions for psychedelic-assisted couples therapy [149].
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Proposes that combining psilocybin-assisted therapy for substance use disorder with MDMA for a partner's codependency in couples therapy may reduce addictive and codependent behaviors.
Synthesized
Comparable studies
Other narrative reviews on MDMA for addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants | 2016 | Review | |
| Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men' | 2004 | Review | |
| Use and abuse of dissociative and psychedelic drugs in adolescence Adolescent humans and preclinical animal models | 2021 | Review | |
| Can MDMA Play a Role in the Treatment of Substance Abuse? | 2013 | Review | |
| Neuroimaging in Human MDMA (Ecstasy) Users | 2008 | Review |
Citations in the library
Cites 41
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
and 36 more in the library